UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2194) 2194
Book Chapter (66) 66
Newsletter (33) 33
Newspaper Article (31) 31
Magazine Article (22) 22
Publication (14) 14
Streaming Video (5) 5
Poster (4) 4
Book / eBook (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dabigatran (1562) 1562
science & technology (1518) 1518
life sciences & biomedicine (1484) 1484
humans (1479) 1479
anticoagulants (855) 855
dabigatran etexilate (769) 769
atrial fibrillation (721) 721
rivaroxaban (711) 711
male (596) 596
anticoagulants - therapeutic use (579) 579
cardiovascular system & cardiology (573) 573
female (537) 537
beta-alanine - analogs & derivatives (509) 509
aged (493) 493
warfarin (489) 489
administration, oral (467) 467
stroke (459) 459
atrial fibrillation - drug therapy (444) 444
benzimidazoles - therapeutic use (436) 436
anticoagulants - adverse effects (422) 422
apixaban (412) 412
anticoagulants - administration & dosage (395) 395
hematology (374) 374
benzimidazoles - adverse effects (370) 370
stroke - prevention & control (360) 360
hemorrhage - chemically induced (347) 347
pharmacology & pharmacy (346) 346
thrombin (339) 339
middle aged (332) 332
peripheral vascular disease (331) 331
cardiac & cardiovascular systems (327) 327
benzimidazoles - administration & dosage (319) 319
risk factors (314) 314
atrial fibrillation - complications (304) 304
thromboembolism (290) 290
drug therapy (285) 285
treatment outcome (274) 274
antithrombins - adverse effects (267) 267
aged, 80 and over (262) 262
pyridines - therapeutic use (246) 246
antithrombins - therapeutic use (236) 236
prevention (235) 235
warfarin - therapeutic use (235) 235
beta-alanine - therapeutic use (234) 234
beta-alanine - adverse effects (229) 229
dosage and administration (229) 229
care and treatment (228) 228
medicine & public health (220) 220
dabigatran - therapeutic use (212) 212
general & internal medicine (212) 212
abridged index medicus (210) 210
blood coagulation - drug effects (204) 204
cardiac arrhythmia (204) 204
dabigatran - adverse effects (203) 203
antithrombins - administration & dosage (202) 202
stroke - etiology (194) 194
medicine, general & internal (192) 192
analysis (190) 190
anticoagulation (185) 185
hemorrhage (183) 183
beta-alanine - administration & dosage (182) 182
dabigatran - administration & dosage (181) 181
bleeding (177) 177
research (176) 176
pyrazoles - therapeutic use (173) 173
pyridones - therapeutic use (173) 173
venous thromboembolism (170) 170
pyridines - administration & dosage (169) 169
warfarin - adverse effects (167) 167
pyridines - adverse effects (165) 165
animals (163) 163
thrombosis (162) 162
cardiology (161) 161
health aspects (159) 159
venous thromboembolism - prevention & control (159) 159
morpholines - therapeutic use (155) 155
thiophenes - therapeutic use (155) 155
edoxaban (150) 150
anticoagulants - pharmacology (147) 147
complications and side effects (142) 142
patients (141) 141
benzimidazoles - pharmacology (140) 140
usage (138) 138
adult (135) 135
internal medicine (135) 135
surgery (127) 127
anticoagulants - pharmacokinetics (126) 126
thrombin - antagonists & inhibitors (125) 125
thromboembolism - prevention & control (125) 125
clinical trials (123) 123
dose-response relationship, drug (123) 123
pyrazoles - administration & dosage (120) 120
pyridones - administration & dosage (120) 120
vitamin k - antagonists & inhibitors (115) 115
benzimidazoles - pharmacokinetics (114) 114
randomized controlled trials as topic (112) 112
warfarin - administration & dosage (108) 108
drug interactions (107) 107
factor xa inhibitors (106) 106
pharmacology (106) 106
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2265) 2265
French (39) 39
German (35) 35
Russian (27) 27
Spanish (26) 26
Japanese (13) 13
Czech (9) 9
Portuguese (6) 6
Italian (5) 5
Chinese (2) 2
Danish (2) 2
Hungarian (2) 2
Arabic (1) 1
Persian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85
Dabigatran etexilate has been investigated in three phase III trials for the prevention of venous thromboembolism (VTE... 
anticoagulants | thrombosis | prophylaxis | Embolism | Meta-analysis | Anticoagulants | Thrombosis | Prophylaxis | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Venous Thromboembolism - mortality | Anticoagulants - administration & dosage | Arthroplasty, Replacement, Knee - adverse effects | Humans | Dabigatran | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - prevention & control | Clinical Trials, Phase III as Topic | Enoxaparin - administration & dosage | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Benzimidazoles - adverse effects | Benzimidazoles - therapeutic use | Pyridines - therapeutic use | Pyridines - administration & dosage | Drug Administration Schedule | Risk Assessment | Administration, Oral | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Arthroplasty, Replacement, Hip - adverse effects | Venous Thromboembolism - etiology | Hemorrhage - chemically induced | Index Medicus | Administration | Phase III as Topic | Benzimidazoles/administration & dosage/adverse effects/therapeutic use | Pyridines/administration & dosage/adverse effects/therapeutic use | Arthroplasty | Replacement | Oral | Clinical Trials | Kirurgi | Knee/adverse effects | Hemorrhage/chemically induced | Venous Thromboembolism/etiology/mortality/prevention & control | Hip/adverse effects | Anticoagulants/administration & dosage/adverse effects/therapeutic use | Surgery | Enoxaparin/administration & dosage/adverse effects/therapeutic use
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 2009, Volume 9, Issue 1, pp. 59 - 68
Background Dabigatran etexilate, a novel oral direct thrombin inhibitor, has been approved for prophylaxis of thromboembolism in patients undergoing total knee or total hip replacement, and is under...